TUSC7 and central nervous system cancer: Compared with glioma patients with higher TUSC7 expression, a lower expression of TUSC7 was associated with a remarkably shorter survival time in Kaplan–Meier analysis (Figure 2C), and a significantly worse prognosis in the univariate Cox proportional hazards regression analysis of overall survival (HR = 2.813, 95% CI: 1.504–6.172; P = 0.017).